Genetic studies have further demonstrated that in ALS patients carrying superoxide dismutase 1 (SOD1) mutations, this process is exacerbated by inflammatory cell activation and myeloperoxidase-mediated oxidative injury (85), underscoring the synergistic pathogenic interplay between neuroinflammation and oxidative stress. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.